Search research articles
Contact Us
Filters
Showing results (241-250 of 267) with videos related to
Page
of 27
Sort By:
Scientific Reports
|
February 15, 2020
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease
Vincenzo Musolino, Micaela Gliozzi, Federica Scarano, et al.
Histopathology
|
May 22, 2024
Severe acute liver disease in adults: Contemporary role of histopathology
Andrew D Clouston, Annette S H Gouw, Dina Tiniakos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 21, 2018
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study
Maud Lemoine, Lambert Assoumou, Stephane De Wit, et al.
The Lancet. Gastroenterology & Hepatology
|
August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
Stephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
The Lancet. Gastroenterology & Hepatology
|
February 7, 2020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N Newsome, Magali Sasso, Jonathan J Deeks, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2021
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes
Thierry Poynard, Valérie Paradis, Jimmy Mullaert, et al.
Journal of Hepatology
|
November 17, 2023
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
Markus Boesch, Andreas Lindhorst, Rita Feio-Azevedo, et al.
JHEP Reports : Innovation in Hepatology
|
June 9, 2025
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
Pierre-Emmanuel Rautou, Shivani Chotkoe, Louise Biquard, et al.
Journal of Hepatology
|
October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials
Carolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
The New England Journal of Medicine
|
October 20, 2021
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M Francque, Pierre Bedossa, Vlad Ratziu, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 267) with videos related to
Sort By:
Page
of 27
Scientific Reports
|
February 15, 2020
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease
Vincenzo Musolino, Micaela Gliozzi, Federica Scarano, et al.
Histopathology
|
May 22, 2024
Severe acute liver disease in adults: Contemporary role of histopathology
Andrew D Clouston, Annette S H Gouw, Dina Tiniakos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 21, 2018
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study
Maud Lemoine, Lambert Assoumou, Stephane De Wit, et al.
The Lancet. Gastroenterology & Hepatology
|
August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
Stephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
The Lancet. Gastroenterology & Hepatology
|
February 7, 2020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N Newsome, Magali Sasso, Jonathan J Deeks, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2021
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes
Thierry Poynard, Valérie Paradis, Jimmy Mullaert, et al.
Journal of Hepatology
|
November 17, 2023
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
Markus Boesch, Andreas Lindhorst, Rita Feio-Azevedo, et al.
JHEP Reports : Innovation in Hepatology
|
June 9, 2025
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
Pierre-Emmanuel Rautou, Shivani Chotkoe, Louise Biquard, et al.
Journal of Hepatology
|
October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials
Carolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
The New England Journal of Medicine
|
October 20, 2021
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M Francque, Pierre Bedossa, Vlad Ratziu, et al.
Page
of 27